Published in Hepatitis Weekly, August 14th, 2000
Four million Americans are infected with the hepatitis C virus. It's estimated that 20% of those patients will eventually develop cirrhosis, liver failure, or liver cancer. More than half of all hepatitis C patients will not respond to current treatment.
"The aim is to identify patients with very advanced liver disease...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.